| scholarly article | Q13442814 |
| P50 | author | Ege T. Kavalali | Q74886885 |
| P2093 | author name string | Ying C Li | |
| P2860 | cites work | SV2 mediates entry of tetanus neurotoxin into central neurons | Q21090499 |
| Quercetin targets cysteine string protein (CSPalpha) and impairs synaptic transmission | Q21562195 | ||
| Amphiphysin, a novel protein associated with synaptic vesicles | Q24294744 | ||
| The synaptic vesicle cycle | Q24297813 | ||
| Complexins: cytosolic proteins that regulate SNAP receptor function | Q24309091 | ||
| Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome "critical region" | Q24309183 | ||
| Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling | Q24311523 | ||
| Cloning of a human homolog of the Drosophila minibrain/rat Dyrk gene from "the Down syndrome critical region" of chromosome 21 | Q24317479 | ||
| Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis | Q24319132 | ||
| LRRK2 regulates synaptic vesicle endocytosis | Q24336523 | ||
| The synucleins | Q24551013 | ||
| The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam | Q24561949 | ||
| De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies | Q24563008 | ||
| Synaptophysin, a major synaptic vesicle protein, is not essential for neurotransmitter release | Q24601743 | ||
| Doc2b is a high-affinity Ca2+ sensor for spontaneous neurotransmitter release | Q24611697 | ||
| Primary afferent activation of thermosensitive TRPV1 triggers asynchronous glutamate release at central neurons | Q24629314 | ||
| Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro | Q24629968 | ||
| Membrane fusion: grappling with SNARE and SM proteins | Q24633113 | ||
| Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A) | Q24655420 | ||
| Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit | Q24678549 | ||
| Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia | Q24678573 | ||
| The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer | Q24680318 | ||
| Synaptotagmin-1 and synaptotagmin-7 trigger synchronous and asynchronous phases of neurotransmitter release | Q26269844 | ||
| Neurotransmitter release: the last millisecond in the life of a synaptic vesicle | Q26269845 | ||
| Deconstructing complexin function in activating and clamping Ca2+-triggered exocytosis by comparing knockout and knockdown phenotypes | Q26269851 | ||
| Distinct neuronal coding schemes in memory revealed by selective erasure of fast synchronous synaptic transmission | Q26269879 | ||
| Doc2 supports spontaneous synaptic transmission by a Ca(2+)-independent mechanism | Q26269899 | ||
| Complexin clamps asynchronous release by blocking a secondary Ca(2+) sensor via its accessory α helix | Q26269900 | ||
| Synaptotagmin-1 functions as a Ca2+ sensor for spontaneous release | Q26269916 | ||
| RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction | Q26269921 | ||
| Synaptotagmin 7 splice variants differentially regulate synaptic vesicle recycling | Q26269972 | ||
| The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential | Q26781422 | ||
| Enhancement of asynchronous release from fast-spiking interneuron in human and rat epileptic neocortex | Q27319486 | ||
| A missense mutation in a highly conserved alternate exon of dynamin-1 causes epilepsy in fitful mice | Q27346832 | ||
| SAC1-like domains of yeast SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases | Q27934132 | ||
| Calcineurin: form and function | Q27934527 | ||
| Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome | Q28117514 | ||
| Rab GTPases as coordinators of vesicle traffic | Q28131746 | ||
| Synucleins are a novel class of substrates for G protein-coupled receptor kinases | Q28138274 | ||
| Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein | Q28141645 | ||
| Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin II | Q28179222 | ||
| Functional interaction of the active zone proteins Munc13-1 and RIM1 in synaptic vesicle priming | Q28188061 | ||
| Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population | Q28201930 | ||
| SNARE function analyzed in synaptobrevin/VAMP knockout mice | Q28203549 | ||
| Synaptotagmin I functions as a calcium regulator of release probability | Q28204147 | ||
| Alpha-synuclein and neurodegenerative diseases | Q28204386 | ||
| Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder | Q28211166 | ||
| RIM1alpha forms a protein scaffold for regulating neurotransmitter release at the active zone | Q28215837 | ||
| Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins | Q28276992 | ||
| Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. | Q28281249 | ||
| Mammalian homologues of Caenorhabditis elegans unc-13 gene define novel family of C2-domain proteins | Q28289561 | ||
| Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia | Q28291484 | ||
| Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism | Q28293555 | ||
| Binding of protein kinase inhibitors to synapsin I inferred from pair-wise binding site similarity measurements | Q28475132 | ||
| Amyloid-β acts as a regulator of neurotransmitter release disrupting the interaction between synaptophysin and VAMP2 | Q28482267 | ||
| Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming | Q28504670 | ||
| The calcium sensor synaptotagmin 7 is required for synaptic facilitation | Q28505395 | ||
| RIM1alpha is required for presynaptic long-term potentiation | Q28508676 | ||
| Distinct pools of synaptic vesicles in neurotransmitter release | Q57649299 | ||
| Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase | Q57976151 | ||
| Protein phosphorylation is required for endocytosis in nerve terminals: potential role for the dephosphins dynamin I and synaptojanin, but not AP180 or amphiphysin | Q57976321 | ||
| Subcellular localization of tetanus neurotoxin-insensitive vesicle-associated membrane protein (VAMP)/VAMP7 in neuronal cells: evidence for a novel membrane compartment | Q57979001 | ||
| Localization of Rab5 to synaptic vesicles identifies endosomal intermediate in synaptic vesicle recycling pathway | Q57979066 | ||
| Overexpression of synaptophysin enhances neurotransmitter secretion at Xenopus neuromuscular synapses | Q59616691 | ||
| Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder | Q60440984 | ||
| A radioassay for synaptic core complex assembly: Screening of herbal extracts for effectors | Q60716347 | ||
| Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation | Q71059970 | ||
| Kinetics of synaptotagmin responses to Ca2+ and assembly with the core SNARE complex onto membranes | Q73203897 | ||
| Recombinant forms of tetanus toxin engineered for examining and exploiting neuronal trafficking pathways | Q74009600 | ||
| Nerve growth factor-induced phosphorylation of amphiphysin-1 by casein kinase 2 regulates clathrin-amphiphysin interactions | Q80196742 | ||
| Long-distance retrograde effects of botulinum neurotoxin A | Q81006671 | ||
| Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies | Q81296212 | ||
| Inhibition of SNARE-driven neuroexocytosis by plant extracts | Q82680538 | ||
| Different pools of postsynaptic GABAA receptors mediate inhibition evoked by low- and high-frequency presynaptic stimulation at hippocampal synapses | Q87544185 | ||
| Single synapse evaluation of the postsynaptic NMDA receptors targeted by evoked and spontaneous neurotransmission | Q37490588 | ||
| Ultrafast endocytosis at mouse hippocampal synapses. | Q37642826 | ||
| Amphiphysin I and regulation of synaptic vesicle endocytosis | Q37662707 | ||
| Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs | Q37676119 | ||
| Kinetic efficiency of endocytosis at mammalian CNS synapses requires synaptotagmin I | Q37692617 | ||
| Ca2+-Calmodulin regulates SNARE assembly and spontaneous neurotransmitter release via v-ATPase subunit V0a1. | Q37703486 | ||
| Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. | Q37714086 | ||
| Spontaneous neurotransmission: an independent pathway for neuronal signaling? | Q37847816 | ||
| α-Synuclein in Parkinson's disease | Q37987146 | ||
| Perspectives on kiss-and-run: role in exocytosis, endocytosis, and neurotransmission | Q38067906 | ||
| Molecular mechanisms for synchronous, asynchronous, and spontaneous neurotransmitter release | Q38166028 | ||
| The mechanisms and functions of spontaneous neurotransmitter release | Q38293976 | ||
| Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder | Q38299200 | ||
| Antisense in vivo knockdown of synaptotagmin I and synapsin I by HVJ-liposome mediated gene transfer modulates ischemic injury of hippocampus in opposing ways | Q38356818 | ||
| Rab3a is involved in transport of synaptic vesicles to the active zone in mouse brain nerve terminals. | Q39226804 | ||
| Development of a high-throughput AlphaScreen assay for modulators of synapsin I phosphorylation in primary neurons | Q39340563 | ||
| A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis | Q39752213 | ||
| Asynchronous presynaptic glutamate release enhances neuronal excitability during the post-spike refractory period. | Q40216542 | ||
| Synaptophysin I controls the targeting of VAMP2/synaptobrevin II to synaptic vesicles. | Q40286914 | ||
| SV2 is the protein receptor for botulinum neurotoxin A. | Q40303506 | ||
| Phosphorylation of dynamin I and synaptic-vesicle recycling | Q40394732 | ||
| Vti1a identifies a vesicle pool that preferentially recycles at rest and maintains spontaneous neurotransmission | Q40442647 | ||
| Molecular mechanisms of clostridial neurotoxins | Q40642444 | ||
| Synaptobrevin binding to synaptophysin: a potential mechanism for controlling the exocytotic fusion machine. | Q40805470 | ||
| Synaptotagmin regulation of coated pit assembly | Q40867065 | ||
| Munc13-1 is a presynaptic phorbol ester receptor that enhances neurotransmitter release | Q41017986 | ||
| Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. | Q41437626 | ||
| Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. | Q41483110 | ||
| Calcineurin inhibition with systemic FK506 treatment increases dendritic branching and dendritic spine density in healthy adult mouse brain | Q41483382 | ||
| The kinetics of transmitter release at the frog neuromuscular junction | Q41512821 | ||
| Synaptic vesicle endocytosis | Q41541520 | ||
| Distinct requirements for evoked and spontaneous release of neurotransmitter are revealed by mutations in the Drosophila gene neuronal-synaptobrevin. | Q41712786 | ||
| Vesicle recycling revisited: rapid endocytosis may be the first step | Q41720900 | ||
| The multisubunit structure of synaptophysin. Relationship between disulfide bonding and homo-oligomerization | Q41733842 | ||
| The role of non-canonical SNAREs in synaptic vesicle recycling | Q41829974 | ||
| Truncations of amphiphysin I by calpain inhibit vesicle endocytosis during neural hyperexcitation | Q41831888 | ||
| Synthetic self-assembling clostridial chimera for modulation of sensory functions | Q41876523 | ||
| α-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis | Q41901772 | ||
| Developing a PPI inhibitor-based therapy for STXBP1 haploinsufficiency-associated epileptic disorders | Q41910332 | ||
| v-SNARE composition distinguishes synaptic vesicle pools. | Q42142233 | ||
| Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain | Q42167604 | ||
| Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease. | Q42274064 | ||
| Fast, Temperature-Sensitive and Clathrin-Independent Endocytosis at Central Synapses | Q42362658 | ||
| Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition | Q42477784 | ||
| A resting pool of vesicles is responsible for spontaneous vesicle fusion at the synapse | Q42547280 | ||
| Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice | Q42586885 | ||
| Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome | Q42801227 | ||
| Role of Drosophila Rab5 during endosomal trafficking at the synapse and evoked neurotransmitter release | Q42917089 | ||
| The association of dynamin with synaptophysin regulates quantal size and duration of exocytotic events in chromaffin cells. | Q42940256 | ||
| Cysteine string protein-alpha prevents activity-dependent degeneration in GABAergic synapses. | Q43053624 | ||
| Asynchronous GABA Release Is a Key Determinant of Tonic Inhibition and Controls Neuronal Excitability: A Study in the Synapsin II-/- Mouse. | Q43100218 | ||
| Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1. | Q43117339 | ||
| UNC-13 is required for synaptic vesicle fusion in C. elegans | Q43240851 | ||
| Acute dynamin inhibition dissects synaptic vesicle recycling pathways that drive spontaneous and evoked neurotransmission | Q33661188 | ||
| Desynchronization of neocortical networks by asynchronous release of GABA at autaptic and synaptic contacts from fast-spiking interneurons. | Q33712158 | ||
| Synchronous and asynchronous transmitter release at nicotinic synapses are differentially regulated by postsynaptic PSD-95 proteins | Q33747790 | ||
| Synucleins regulate the kinetics of synaptic vesicle endocytosis. | Q33865356 | ||
| AP-2 recruitment to synaptotagmin stimulated by tyrosine-based endocytic motifs | Q33871607 | ||
| Neurotoxins affecting neuroexocytosis | Q33881286 | ||
| Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. | Q33887879 | ||
| Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigra | Q33938966 | ||
| Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles. | Q33948657 | ||
| Properties of synchronous and asynchronous release during pulse train depression in cultured hippocampal neurons | Q33949457 | ||
| Anxiolytic-like effects of extracts from Albizzia julibrissin bark in the elevated plus-maze in rats | Q33982048 | ||
| Synaptic vesicle pools | Q33983958 | ||
| Complexin inhibits spontaneous release and synchronizes Ca2+-triggered synaptic vesicle fusion by distinct mechanisms | Q34033326 | ||
| SV2 acts via presynaptic calcium to regulate neurotransmitter release. | Q34034957 | ||
| A high-throughput screen to identify novel calcineurin inhibitors | Q34067826 | ||
| Distinct roles for two synaptotagmin isoforms in synchronous and asynchronous transmitter release at zebrafish neuromuscular junction | Q34068556 | ||
| A trimeric protein complex functions as a synaptic chaperone machine. | Q34093245 | ||
| The SNAREs vti1a and vti1b have distinct localization and SNARE complex partners | Q34133588 | ||
| Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters | Q34161514 | ||
| Three modes of synaptic vesicular recycling revealed by single-vesicle imaging | Q34203451 | ||
| Evidence for recycling of synaptic vesicle membrane during transmitter release at the frog neuromuscular junction | Q34207383 | ||
| Turnover of transmitter and synaptic vesicles at the frog neuromuscular junction | Q34207387 | ||
| Endocytosis and intracellular trafficking contribute to necrotic neurodegeneration in C. elegans | Q34239748 | ||
| α-Synuclein knockout mice have cognitive impairments. | Q34265318 | ||
| The membrane fusion enigma: SNAREs, Sec1/Munc18 proteins, and their accomplices--guilty as charged? | Q34305507 | ||
| The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. | Q34314406 | ||
| Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse | Q34321656 | ||
| Short-term synaptic plasticity is altered in mice lacking synapsin I. | Q34321716 | ||
| Cysteine string proteins: a potential link between synaptic vesicles and presynaptic Ca2+ channels | Q34321980 | ||
| Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease. | Q34327884 | ||
| Synaptotagmin I is a high affinity receptor for clathrin AP-2: implications for membrane recycling | Q34334008 | ||
| Working memory impairment in calcineurin knock-out mice is associated with alterations in synaptic vesicle cycling and disruption of high-frequency synaptic and network activity in prefrontal cortex | Q34355386 | ||
| Different presynaptic roles of synapsins at excitatory and inhibitory synapses. | Q34376922 | ||
| Accumulation of α-synuclein triggered by presynaptic dysfunction | Q48273115 | ||
| Phosphorylated synaphin/complexin found in the brain exhibits enhanced SNARE complex binding | Q48291901 | ||
| A gain-of-function mutation in synaptotagmin-1 reveals a critical role of Ca2+-dependent soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex binding in synaptic exocytosis. | Q48352739 | ||
| Association of intronic polymorphism rs3773364 A>G in synapsin-2 gene with idiopathic epilepsy | Q48369166 | ||
| Protein kinase A-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity. | Q48375591 | ||
| Small molecule-mediated stabilization of vesicle-associated helical α-synuclein inhibits pathogenic misfolding and aggregation | Q48406052 | ||
| Proteasome inhibition alleviates SNARE-dependent neurodegeneration | Q48407910 | ||
| Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy. | Q48458333 | ||
| Synaptotagmin: a calcium sensor on the synaptic vesicle surface | Q48480063 | ||
| Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4. | Q48482230 | ||
| Upregulated dynamin 1 in an acute seizure model and in epileptic patients. | Q48484357 | ||
| A novel STXBP1 mutation causes focal seizures with neonatal onset | Q48506471 | ||
| Postnatal development of phase-locked high-fidelity synaptic transmission in the medial nucleus of the trapezoid body of the rat. | Q48558660 | ||
| Forskolin supresses seizures induced by pentylenetrazol in mice | Q48601846 | ||
| Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. | Q48650804 | ||
| Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease | Q48657276 | ||
| Absence of TI-VAMP/Vamp7 leads to increased anxiety in mice | Q48666076 | ||
| Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease | Q48882042 | ||
| Alpha-synuclein binding to rab3a in multiple system atrophy. | Q48912140 | ||
| Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex | Q49080781 | ||
| Serotonin transporter phosphorylation modulated by tetanus toxin | Q49160079 | ||
| Inhibitory transmission mediated by asynchronous transmitter release. | Q50495483 | ||
| Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation. | Q50577139 | ||
| Botulinum neurotoxin A subtype 2 reduces pathological behaviors more effectively than subtype 1 in a rat Parkinson's disease model. | Q50853892 | ||
| Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations. | Q51836559 | ||
| Ca2+ regulates the interaction between synaptotagmin and syntaxin 1. | Q52508040 | ||
| Reduced in vitro phosphorylation of synapsin I (site 1) in Alzheimer's disease postmortem tissues | Q53182572 | ||
| CSPα promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity. | Q54397791 | ||
| Dynamin 1 isoform roles in a mouse model of severe childhood epileptic encephalopathy. | Q54901806 | ||
| Neurotransmitter release: fusion or 'kiss-and-run'? | Q55038012 | ||
| Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction | Q43552239 | ||
| Fast kinetics of exocytosis revealed by simultaneous measurements of presynaptic capacitance and postsynaptic currents at a central synapse | Q43601414 | ||
| Down-regulation of synaptotagmin 1 in cortex, hippocampus, and cerebellum after experimental subarachnoid hemorrhage | Q43643831 | ||
| Synaptojanin 1 contributes to maintaining the stability of GABAergic transmission in primary cultures of cortical neurons. | Q43805328 | ||
| Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory | Q43815520 | ||
| Ca2+-dependent formation of a dynamin-synaptophysin complex: potential role in synaptic vesicle endocytosis. | Q43847047 | ||
| Fast vesicle recycling supports neurotransmission during sustained stimulation at hippocampal synapses. | Q43906969 | ||
| Transgenically encoded protein photoinactivation (FlAsH-FALI): acute inactivation of synaptotagmin I. | Q44239529 | ||
| Intraterminal Ca2+ concentration and asynchronous transmitter release at single GABAergic boutons in rat collicular cultures | Q44364051 | ||
| SNAP-25 reduction in the hippocampus of patients with schizophrenia. | Q44400959 | ||
| Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy | Q44416102 | ||
| Early epileptic encephalopathies associated with STXBP1 mutations: Could we better delineate the phenotype? | Q44639297 | ||
| Small peptides patterned after the N-terminus domain of SNAP25 inhibit SNARE complex assembly and regulated exocytosis | Q44693096 | ||
| Competition between phasic and asynchronous release for recovered synaptic vesicles at developing hippocampal autaptic synapses. | Q44728721 | ||
| Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity | Q44736849 | ||
| Synaptobrevin is essential for fast synaptic-vesicle endocytosis | Q45099773 | ||
| Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease | Q45172855 | ||
| An isolated pool of vesicles recycles at rest and drives spontaneous neurotransmission | Q45274254 | ||
| Antiepileptic effects of botulinum neurotoxin E. | Q45281121 | ||
| Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease | Q45302047 | ||
| Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease. | Q45304640 | ||
| Abnormal phosphorylation of synapsin I predicts a neuronal transmission impairment in the R6/2 Huntington's disease transgenic mice | Q45306790 | ||
| Phosphorylation and nitration of tyrosine residues affect functional properties of Synaptophysin and Dynamin I, two proteins involved in exo-endocytosis of synaptic vesicles | Q45374195 | ||
| Botulinum neurotoxin A2 reduces incidence of seizures in mouse models of temporal lobe epilepsy. | Q45913591 | ||
| Vesicle-associated membrane protein and synaptophysin are associated on the synaptic vesicle. | Q46032554 | ||
| Synaptotagmin I is necessary for compensatory synaptic vesicle endocytosis in vivo | Q46083214 | ||
| Rapid reuse of readily releasable pool vesicles at hippocampal synapses | Q46167177 | ||
| Opposite changes in glutamatergic and GABAergic transmission underlie the diffuse hyperexcitability of synapsin I-deficient cortical networks | Q46237364 | ||
| Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis. | Q46267461 | ||
| Effect of chronic Albizzia julibrissin treatment on 5-hydroxytryptamine1A receptors in rat brain | Q46490718 | ||
| Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse | Q46699474 | ||
| Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study | Q46969020 | ||
| Fast synaptic fatigue in shibire mutants reveals a rapid requirement for dynamin in synaptic vesicle membrane trafficking | Q47070147 | ||
| A complexin fusion clamp regulates spontaneous neurotransmitter release and synaptic growth | Q47072408 | ||
| Size of vesicle pools, rates of mobilization, and recycling at neuromuscular synapses of a Drosophila mutant, shibire | Q47220778 | ||
| Association between schizophrenia and the syntaxin 1A gene. | Q47286205 | ||
| Phosphorylation of synapsin I by cyclin-dependent kinase-5 sets the ratio between the resting and recycling pools of synaptic vesicles at hippocampal synapses. | Q47867914 | ||
| Fusion pore dynamics are regulated by synaptotagmin*t-SNARE interactions. | Q47874870 | ||
| Calcium triggers calcineurin-dependent synaptic vesicle recycling in mammalian nerve terminals | Q47889987 | ||
| SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family | Q47894520 | ||
| A complete genetic analysis of neuronal Rab3 function. | Q47952687 | ||
| Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia | Q48021583 | ||
| The role of Rab3A in neurotransmitter release | Q48106348 | ||
| Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking. | Q48114674 | ||
| Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial | Q48130509 | ||
| Integration of asynchronously released quanta prolongs the postsynaptic spike window | Q48130809 | ||
| Excitotoxicity-related endocytosis in cortical neurons | Q48201186 | ||
| Uncoupling the roles of synaptotagmin I during endo- and exocytosis of synaptic vesicles. | Q36212557 | ||
| The synaptic vesicle cycle: a single vesicle budding step involving clathrin and dynamin | Q36237077 | ||
| Synaptic vesicles have two distinct recycling pathways | Q36237608 | ||
| Single-vesicle imaging reveals that synaptic vesicle exocytosis and endocytosis are coupled by a single stochastic mode | Q36300120 | ||
| Palmitoylation-induced aggregation of cysteine-string protein mutants that cause neuronal ceroid lipofuscinosis | Q36347832 | ||
| Synaptic vesicle reuse and its implications | Q36361004 | ||
| Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal | Q36455215 | ||
| Dynamin, a membrane-remodelling GTPase | Q36460251 | ||
| Action of botulinum neurotoxins in the central nervous system: antiepileptic effects. | Q36511621 | ||
| Synaptic vesicle generation from activity-dependent bulk endosomes requires calcium and calcineurin. | Q36660705 | ||
| α-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity. | Q36685114 | ||
| Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons | Q36692413 | ||
| Epileptic encephalopathy-causing mutations in DNM1 impair synaptic vesicle endocytosis. | Q36766098 | ||
| α-Synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers | Q36806739 | ||
| Frequency-dependent modes of synaptic vesicle endocytosis and exocytosis at adult mouse neuromuscular junctions | Q36812971 | ||
| Phosphorylation of Complexin by PKA Regulates Activity-Dependent Spontaneous Neurotransmitter Release and Structural Synaptic Plasticity | Q36844167 | ||
| Synaptic vesicle fusion | Q36844178 | ||
| Acute suppression of spontaneous neurotransmission drives synaptic potentiation | Q36866368 | ||
| Multiple vesicle recycling pathways in central synapses and their impact on neurotransmission | Q36906517 | ||
| Vesicular neurotransmitter transporters as targets for endogenous and exogenous toxic substances | Q36947112 | ||
| Ca(2+) and calmodulin initiate all forms of endocytosis during depolarization at a nerve terminal. | Q36951925 | ||
| Spontaneous and evoked glutamate release activates two populations of NMDA receptors with limited overlap | Q36962792 | ||
| Reduction of synaptojanin 1 ameliorates synaptic and behavioral impairments in a mouse model of Alzheimer's disease | Q37013968 | ||
| Dynamin phosphorylation controls optimization of endocytosis for brief action potential bursts | Q37057969 | ||
| Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system | Q37075340 | ||
| Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease | Q37083085 | ||
| Neurodegenerative changes initiated by presynaptic dysfunction | Q37112980 | ||
| X-linked intellectual disability-associated mutations in synaptophysin disrupt synaptobrevin II retrieval | Q37128130 | ||
| The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures | Q37215037 | ||
| Reelin mobilizes a VAMP7-dependent synaptic vesicle pool and selectively augments spontaneous neurotransmission | Q37341638 | ||
| Synchronous and asynchronous modes of synaptic transmission utilize different calcium sources | Q37405978 | ||
| Voltage-gated potassium channels as therapeutic targets | Q37464784 | ||
| Synapsin II and Rab3a cooperate in the regulation of epileptic and synaptic activity in the CA1 region of the hippocampus | Q37484739 | ||
| The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis | Q34416249 | ||
| Synapsins I and II are ATP-binding proteins with differential Ca2+ regulation | Q34452467 | ||
| Development of second-generation indole-based dynamin GTPase inhibitors | Q34483476 | ||
| Distinct endocytic pathways control the rate and extent of synaptic vesicle protein recycling | Q34568799 | ||
| Integrating molecular and network biology to decode endocytosis | Q34666235 | ||
| Different dynamin blockers interfere with distinct phases of synaptic endocytosis during stimulation in motoneurones | Q34669847 | ||
| DNA variation in the SNAP25 gene confers risk to ADHD and is associated with reduced expression in prefrontal cortex | Q34672850 | ||
| Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors. | Q34705504 | ||
| Fast retrieval and autonomous regulation of single spontaneously recycling synaptic vesicles | Q34729313 | ||
| Use-dependent AMPA receptor block reveals segregation of spontaneous and evoked glutamatergic neurotransmission | Q34911758 | ||
| Differential regulation of spontaneous and evoked neurotransmitter release at central synapses | Q34975491 | ||
| Detection of behavioral alterations and learning deficits in mice lacking synaptophysin. | Q34977739 | ||
| Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters. | Q34988000 | ||
| Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis | Q35058315 | ||
| Desynchronization of multivesicular release enhances Purkinje cell output | Q35140624 | ||
| Binding of the complexin N terminus to the SNARE complex potentiates synaptic-vesicle fusogenicity. | Q35210372 | ||
| Development of quinone analogues as dynamin GTPase inhibitors | Q35217176 | ||
| A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam | Q35217702 | ||
| Synaptophysin is required for synaptobrevin retrieval during synaptic vesicle endocytosis | Q35281762 | ||
| Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease | Q35359220 | ||
| Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling | Q35408613 | ||
| Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy | Q35444901 | ||
| Calcineurin regulation of neuronal plasticity | Q35586583 | ||
| Ca²⁺ influx slows single synaptic vesicle endocytosis | Q35605344 | ||
| 1,8-Naphthalimide derivatives: new leads against dynamin I GTPase activity | Q35676521 | ||
| Central effects of botulinum toxin type A: evidence and supposition. | Q35693979 | ||
| Endocytic pathway alterations in human hippocampus after global ischemia and the influence of APOE genotype | Q35748907 | ||
| Botulinum toxin in clinical practice | Q35807826 | ||
| Linking lipids to Alzheimer's disease: cholesterol and beyond | Q35875480 | ||
| VAMP4 directs synaptic vesicles to a pool that selectively maintains asynchronous neurotransmission | Q35916627 | ||
| Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context | Q35950435 | ||
| Two components of transmitter release at a central synapse | Q36013914 | ||
| Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke | Q36036681 | ||
| Molecular underpinnings of synaptic vesicle pool heterogeneity | Q36083087 | ||
| Complexins regulate a late step in Ca2+-dependent neurotransmitter release | Q31859100 | ||
| Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia. | Q33213888 | ||
| An efficient drug delivery vehicle for botulism countermeasure | Q33513008 | ||
| Screening assay for small-molecule inhibitors of synaptojanin 1, a synaptic phosphoinositide phosphatase | Q33561690 | ||
| Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression | Q33639389 | ||
| Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice | Q28510217 | ||
| Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein | Q28511573 | ||
| Essential role of phosphoinositide metabolism in synaptic vesicle recycling | Q28511682 | ||
| Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons | Q28512527 | ||
| SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release | Q28512897 | ||
| Overlapping role of dynamin isoforms in synaptic vesicle endocytosis | Q28513338 | ||
| Development of a Fluorescent Quenching Based High Throughput Assay to Screen for Calcineurin Inhibitors | Q28546525 | ||
| SV2, a brain synaptic vesicle protein homologous to bacterial transporters | Q28566808 | ||
| Munc13-1 is required for presynaptic long-term potentiation | Q28568366 | ||
| The involvement of the small GTP-binding protein Rab5a in neuronal endocytosis | Q28571235 | ||
| Synapsins: mosaics of shared and individual domains in a family of synaptic vesicle phosphoproteins | Q28574559 | ||
| Rim is a putative Rab3 effector in regulating synaptic-vesicle fusion | Q28575529 | ||
| Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis | Q28580852 | ||
| The SNARE Vti1a-beta is localized to small synaptic vesicles and participates in a novel SNARE complex | Q28581773 | ||
| Essential functions of synapsins I and II in synaptic vesicle regulation | Q28584865 | ||
| Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse | Q28587672 | ||
| Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration | Q28587785 | ||
| Delayed reentry of recycling vesicles into the fusion-competent synaptic vesicle pool in synaptojanin 1 knockout mice | Q28590195 | ||
| Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis | Q28591459 | ||
| Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system | Q28594502 | ||
| Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment | Q29547294 | ||
| Synaptic assembly of the brain in the absence of neurotransmitter secretion | Q29618899 | ||
| The synaptic vesicle cycle: a cascade of protein-protein interactions | Q29620168 | ||
| Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition | Q30009070 | ||
| Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis | Q30009567 | ||
| Amphiphysin I is associated with coated endocytic intermediates and undergoes stimulation-dependent dephosphorylation in nerve terminals | Q30176331 | ||
| Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions | Q30176576 | ||
| Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat. | Q30405084 | ||
| NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses | Q30471587 | ||
| Anticonvulsant Activity of Extracts of Plectranthus barbatus Leaves in Mice | Q30475019 | ||
| Cell- and stimulus-dependent heterogeneity of synaptic vesicle endocytic recycling mechanisms revealed by studies of dynamin 1-null neurons | Q30483551 | ||
| The dynamic control of kiss-and-run and vesicular reuse probed with single nanoparticles | Q30488206 | ||
| Presynaptic kainate receptor activation preserves asynchronous GABA release despite the reduction in synchronous release from hippocampal cholecystokinin interneurons | Q30496566 | ||
| Identification of differentially expressed genes in rat hippocampus after transient global cerebral ischemia using subtractive cDNA cloning based on polymerase chain reaction | Q30661014 | ||
| Identification of SNARE complex modulators that inhibit exocytosis from an alpha-helix-constrained combinatorial library | Q30960561 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 141-160 | |
| P577 | publication date | 2017-04-01 | |
| P1433 | published in | Pharmacological Reviews | Q2085079 |
| P1476 | title | Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets | |
| P478 | volume | 69 |
| Q102369303 | ERICH3: vesicular association and antidepressant treatment response |
| Q47222228 | Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex |
| Q99418007 | Presynaptic dysfunction in CASK-related neurodevelopmental disorders |
| Q45872724 | STXBP1 as a therapeutic target for epileptic encephalopathy |
| Q94454332 | Synaptic dysfunction induced by glycine-alanine dipeptides in C9orf72-ALS/FTD is rescued by SV2 replenishment |
| Q98513674 | Systems biology reveals reprogramming of the S-nitroso-proteome in the cortical and striatal regions of mice during aging process |
| Q92527515 | The effect of NAMPT deletion in projection neurons on the function and structure of neuromuscular junction (NMJ) in mice |
| Q92459461 | Two Pathways for the Activity-Dependent Growth and Differentiation of Synaptic Boutons in Drosophila |
Search more.